Early Recovery: Shifts in Focus
The early recovery period is critical to supporting ongoing recovery efforts. There are many pitfalls, with continued disruption of sleep, mood fluctuations and changing ways to care for yourself. Dr. Mandell will explore these areas providing tips about when and what might be helpful for pharmacological and treatment considerations.
Participants will be able to assist patients with the identification of post-withdrawal symptoms and refer for management.
Participants will be able to provide patients with education and skills regarding affect management as it pertains to recovery.
Participants will be able to address within their scope of practice issues such as overall well-being and self-care including healthy nutrition and sleep hygiene.
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals
1 Category I contact hour for psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
1 contact hour pending for alcohol and drug counselors from the board of alcohol and drug counselors
Todd MandellMD. FASAM
Dr. Mandell, MD. FASAM is an Addictions Psychiatrist with more than 30 years in the field including direct service provision and supervisory/ administrative experience. He currently works for the Bizzell Group, as the Principle Investigator for the NIDA Clinical Trials Network Dissemination Initiative contract.